228 results
8-K
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
.
In addition, as a non-employee director, Ms. Pax will receive the other compensation benefits provided under the Director Compensation Policy
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
integrate any acquired businesses (including Metenova and FlexBiosys) into our business and achieve the expected benefits of such acquisitions; that demand
8-K
EX-4.1
RGEN
Repligen Corp.
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
Holidays
Section 17.07.
No Security Interest Created
Section 17.08.
Benefits of Indenture
Section 17.09.
Table of Contents, Headings, Etc.
Section 17.10 … be entitled to the benefits of this Indenture or be valid or obligatory for any purpose. Such certificate by the Trustee (or such an authenticating
8-K
EX-99.1
64sx6pkhmz 8lb32kw
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
EX-99.2
r8t45q6g0xklcn1en
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
EX-99.1
xshbp al2j
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
EX-10.1
r4zdn3c pb6rfxddubc
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
f5lo q0udyc
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
37tuh
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
xoewvhg
12 Apr 23
Regulation FD Disclosure
7:31am
8-K
EX-99.1
cuk69886
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am